# OSELTAMIVIR PHOSPHATE
> **ANDA217303** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2024-07-02
## Drug
- **FDA Application Number:** ANDA217303
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OSELTAMIVIR PHOSPHATE
- **Generic name:** OSELTAMIVIR PHOSPHATE
- **Active ingredients:** OSELTAMIVIR PHOSPHATE
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PHARMOBEDIENT
- **Manufacturer:** Oryza Pharmaceuticals Inc.
- **First approval:** 2024-07-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217303)
---
*AI Analytics · CC0 1.0*